Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury

Go back to Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
(NASDAQ: SILO) Delayed: 6.02 +0.01 (0.17%)
Previous Close $6.01    52 Week High
Open $6.02    52 Week Low
Day High $6.02    P/E N/A 
Day Low $6.02    EPS
Volume 109,358